Cargando…

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells

BACKGROUND: Although cancer of the prostate is one of the most commonly diagnosed cancers in men, no curative treatment currently exists after its progression beyond resectable boundaries. Therefore, new agents for targeted treatment strategies are needed. Cross-linking of tumor antigens with T-cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bühler, P., Wolf, P., Gierschner, D., Schaber, I., Katzenwadel, A., Schultze-Seemann, W., Wetterauer, U., Tacke, M., Swamy, M., Schamel, W. W. A., Elsässer-Beile, U.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755730/ https://www.ncbi.nlm.nih.gov/pubmed/17579857 http://dx.doi.org/10.1007/s00262-007-0348-6

Ejemplares similares

Enhanced expression of IFN- γ mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer
por: Elsässer-Beile, U, et al.
Publicado: (2000)

Functional Domain Order of an Anti-EGFR × Anti-CD16 Bispecific Diabody Involving NK Cell Activation
por: Kuwahara, Atsushi, et al.
Publicado: (2020)

Patterns of cytokines and lymphocyte subsets in patients with breast and prostate cancer treated with a standardized mistletoe extract preparation
por: Wetzel, D, et al.
Publicado: (2001)

In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer
por: Michalska, Marta, et al.
Publicado: (2016)

Bispecific protein targets prostate cancer
por: Burgess, Antony W.
Publicado: (2017)

Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity
por: Asano, Ryutaro, et al.
Publicado: (2018)

Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats
por: Asano, Ryutaro, et al.
Publicado: (2020)

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy
por: Yuan, Qingyun, et al.
Publicado: (2021)

Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
por: Krönig, Malte, et al.
Publicado: (2017)

Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages.
por: Elsässer-Beile, U., et al.
Publicado: (1993)

A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells
por: Cruz, Jonathan W., et al.
Publicado: (2019)

Spontaneous Tumor Lysis Syndrome in Prostate Cancer
por: Pina Cabral, João, et al.
Publicado: (2021)

Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
por: Asano, Ryutaro, et al.
Publicado: (2014)

Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer
por: Jilg, Cordula A., et al.
Publicado: (2017)

Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer
por: Simão, Diana C., et al.
Publicado: (2023)

Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity
por: Mølgaard, K, et al.
Publicado: (2017)

Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) Induces Apoptosis in LNCaP Prostate Cancer Cells
por: Augspach, Anke, et al.
Publicado: (2013)

Design and preclinical evaluation of a (99m)Tc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
por: Kampmeier, Florian, et al.
Publicado: (2014)

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
por: Gameiro, Sofia R., et al.
Publicado: (2016)

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis
por: Dahut, Madeline, et al.
Publicado: (2023)

Generation and Characterization of a Diabody Targeting the α(v)β(6) Integrin
por: Kogelberg, Heide, et al.
Publicado: (2013)

Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives
por: Heitmann, Jonas S., et al.
Publicado: (2021)

Androgen deprivation therapy increases the sensitivity of human prostate carcinoma cells to T cell-mediated lysis through an androgen receptor dependent mechanism
por: Gameiro, Sofia, et al.
Publicado: (2014)

Quantification of cell surface proteins with bispecific antibodies
por: Panke, C., et al.
Publicado: (2013)

Spontaneous Tumor Lysis Syndrome as Presenting Sign of Metastatic Prostate Cancer
por: McGhee-Jez, Amy, et al.
Publicado: (2018)

DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents
por: Chooniedass, Shilpa, et al.
Publicado: (2016)

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer
por: Zarrabi, Kevin K., et al.
Publicado: (2023)

Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative Men
por: Kroenig, Malte, et al.
Publicado: (2016)

Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in Pichia pastoris and Evaluation of Antitumor Activity In Vivo
por: Xiong, Chenghao, et al.
Publicado: (2018)

A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells
por: Lund, Maria E., et al.
Publicado: (2020)

Urate Nephropathy from Tumor Lysis Syndrome in an Undiagnosed Case of Prostate Cancer
por: Javed, Sidra
Publicado: (2021)

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.
por: Adams, G. P., et al.
Publicado: (1998)

Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer
por: Cai, Yaxiong, et al.
Publicado: (2017)

Fermentation, Purification, and Tumor Inhibition of a Disulfide-Stabilized Diabody Against Fibroblast Growth Factor-2
por: Zhang, Simin, et al.
Publicado: (2021)

A Continuous Flow-through Microfluidic Device for Electrical Lysis of Cells
por: Lo, Ying-Jie, et al.
Publicado: (2019)

Epidural Lysis of Adhesions
por: Lee, Frank, et al.
Publicado: (2014)

Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2
por: Behdani, Mahdi, et al.
Publicado: (2012)

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994)

Low-pressure monopolar electroresection of the prostate for glands sized > 70 vs. < 70 cc performed with continuous irrigation and suprapubic suction: perioperative and long-term outcome
por: Wilhelm, Konrad, et al.
Publicado: (2018)

Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
por: Bruynck, A., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_7gcdl69p58ucfuulmg9i2bnc9l